Cargando…
Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis
Background: Low vitamin D levels may synergize with changing levels of the vitamin D binding protein (DBP) to precipitate in the development and clinical progression of multiple sclerosis (MS). In this study, this hypothesis was explored in groups of Kuwaiti healthy controls and patients with differ...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376961/ https://www.ncbi.nlm.nih.gov/pubmed/37509448 http://dx.doi.org/10.3390/biomedicines11071808 |
_version_ | 1785079398678921216 |
---|---|
author | Al-Shammri, Suhail Chattopadhyay, Arpita Hanah, Magdy Girgis Doi, Suhail Akanji, Abayomi |
author_facet | Al-Shammri, Suhail Chattopadhyay, Arpita Hanah, Magdy Girgis Doi, Suhail Akanji, Abayomi |
author_sort | Al-Shammri, Suhail |
collection | PubMed |
description | Background: Low vitamin D levels may synergize with changing levels of the vitamin D binding protein (DBP) to precipitate in the development and clinical progression of multiple sclerosis (MS). In this study, this hypothesis was explored in groups of Kuwaiti healthy controls and patients with different clinical phenotypes of MS. Methods: Fasting serum concentrations of 25-hydroxyvitamin D [25(OH)D] and DBP were measured in 146 healthy controls and 195 patients with MS. The latter were classified according to the duration, type, and onset of the disease and the mode of treatment. Factors such as relapse/remitting, and the use of nutritional supplements were also considered. Results: The DBP levels were significantly lower in the patients than in the controls. This was more evident in newly diagnosed drug-naïve patients than in those patients with more established MS. MS status and severity were negatively impacted by concurrently low levels of 25(OH)D and DBP. This was most clearly expressed in drug-naïve patients and in those with a disease in relapse. It was also established that the 25(OH)D level had a significant positive correlation with the duration of the disease. Conclusion: Lower levels of 25(OH)D and DBP appear to have a synergistic effect on MS status. This was most clearly demonstrated in patients who were newly diagnosed (drug-naïve) and in those patients who were in relapse. |
format | Online Article Text |
id | pubmed-10376961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103769612023-07-29 Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis Al-Shammri, Suhail Chattopadhyay, Arpita Hanah, Magdy Girgis Doi, Suhail Akanji, Abayomi Biomedicines Article Background: Low vitamin D levels may synergize with changing levels of the vitamin D binding protein (DBP) to precipitate in the development and clinical progression of multiple sclerosis (MS). In this study, this hypothesis was explored in groups of Kuwaiti healthy controls and patients with different clinical phenotypes of MS. Methods: Fasting serum concentrations of 25-hydroxyvitamin D [25(OH)D] and DBP were measured in 146 healthy controls and 195 patients with MS. The latter were classified according to the duration, type, and onset of the disease and the mode of treatment. Factors such as relapse/remitting, and the use of nutritional supplements were also considered. Results: The DBP levels were significantly lower in the patients than in the controls. This was more evident in newly diagnosed drug-naïve patients than in those patients with more established MS. MS status and severity were negatively impacted by concurrently low levels of 25(OH)D and DBP. This was most clearly expressed in drug-naïve patients and in those with a disease in relapse. It was also established that the 25(OH)D level had a significant positive correlation with the duration of the disease. Conclusion: Lower levels of 25(OH)D and DBP appear to have a synergistic effect on MS status. This was most clearly demonstrated in patients who were newly diagnosed (drug-naïve) and in those patients who were in relapse. MDPI 2023-06-24 /pmc/articles/PMC10376961/ /pubmed/37509448 http://dx.doi.org/10.3390/biomedicines11071808 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Al-Shammri, Suhail Chattopadhyay, Arpita Hanah, Magdy Girgis Doi, Suhail Akanji, Abayomi Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis |
title | Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis |
title_full | Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis |
title_fullStr | Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis |
title_full_unstemmed | Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis |
title_short | Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis |
title_sort | association of blood levels of vitamin d and its binding protein with clinical phenotypes of multiple sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376961/ https://www.ncbi.nlm.nih.gov/pubmed/37509448 http://dx.doi.org/10.3390/biomedicines11071808 |
work_keys_str_mv | AT alshammrisuhail associationofbloodlevelsofvitamindanditsbindingproteinwithclinicalphenotypesofmultiplesclerosis AT chattopadhyayarpita associationofbloodlevelsofvitamindanditsbindingproteinwithclinicalphenotypesofmultiplesclerosis AT hanahmagdygirgis associationofbloodlevelsofvitamindanditsbindingproteinwithclinicalphenotypesofmultiplesclerosis AT doisuhail associationofbloodlevelsofvitamindanditsbindingproteinwithclinicalphenotypesofmultiplesclerosis AT akanjiabayomi associationofbloodlevelsofvitamindanditsbindingproteinwithclinicalphenotypesofmultiplesclerosis |